NO892229D0 - Fremgangsmaate for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament. - Google Patents

Fremgangsmaate for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament.

Info

Publication number
NO892229D0
NO892229D0 NO892229A NO892229A NO892229D0 NO 892229 D0 NO892229 D0 NO 892229D0 NO 892229 A NO892229 A NO 892229A NO 892229 A NO892229 A NO 892229A NO 892229 D0 NO892229 D0 NO 892229D0
Authority
NO
Norway
Prior art keywords
dosage form
oral dosage
medicine
preparing
procedure
Prior art date
Application number
NO892229A
Other languages
English (en)
Other versions
NO176232C (no
NO176232B (no
NO892229L (no
Inventor
Joanne Heafield
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Philip John Neale
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NO892229D0 publication Critical patent/NO892229D0/no
Publication of NO892229L publication Critical patent/NO892229L/no
Publication of NO176232B publication Critical patent/NO176232B/no
Publication of NO176232C publication Critical patent/NO176232C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO892229A 1988-06-02 1989-06-01 Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament NO176232C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813064A GB8813064D0 (en) 1988-06-02 1988-06-02 Controlled release dosage forms having defined water content

Publications (4)

Publication Number Publication Date
NO892229D0 true NO892229D0 (no) 1989-06-01
NO892229L NO892229L (no) 1989-12-04
NO176232B NO176232B (no) 1994-11-21
NO176232C NO176232C (no) 1995-03-01

Family

ID=10637952

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892229A NO176232C (no) 1988-06-02 1989-06-01 Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament

Country Status (19)

Country Link
US (1) US5091189A (no)
EP (1) EP0344960B1 (no)
JP (1) JPH0816060B2 (no)
KR (1) KR0136279B1 (no)
AT (1) ATE83925T1 (no)
AU (1) AU610401B2 (no)
CA (1) CA1323834C (no)
DE (1) DE68904119T2 (no)
DK (1) DK175130B1 (no)
ES (1) ES2053989T3 (no)
FI (1) FI93695C (no)
GB (2) GB8813064D0 (no)
GR (1) GR3007088T3 (no)
IE (1) IE61998B1 (no)
IL (1) IL90462A (no)
NO (1) NO176232C (no)
NZ (1) NZ229372A (no)
PT (1) PT90722B (no)
ZA (1) ZA894201B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6277384B1 (en) 1997-12-22 2001-08-21 Euro-Celtique S.A. Opioid agonist/antagonist combinations
PL341309A1 (en) * 1997-12-22 2001-04-09 Euro Celtique Method of preventing overdosage of opioidic preparations
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
PT1255547E (pt) 2000-02-08 2008-11-24 Euro Celtique Sa Composições de libertação controlada contendo agonistas e antagonistas opióides
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
PT1416842E (pt) * 2001-07-18 2009-03-31 Euro Celtique Sa Composições farmacêuticas de oxicodona e naloxona
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
WO2003013433A2 (en) 2001-08-06 2003-02-20 Euro-Celtique S.A. Sequestered antagonist formulations
PL367427A1 (en) 2001-08-06 2005-02-21 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
IN192180B (no) * 2001-09-28 2004-03-06 Ranbaxy Lab
ES2399880T3 (es) * 2002-03-15 2013-04-04 Cypress Bioscience, Inc. Milnaciprán para el tratamiento del síndrome del intestino irritable
MXPA04009713A (es) 2002-04-05 2005-01-11 Euro Celtique Sa Preparacion farmaceutica que contiene oxicodona y naloxona.
DK1551372T3 (en) * 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) * 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
SI1811957T1 (sl) * 2004-10-19 2009-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Trden farmacevtski sestavek, ki obsega donepezil hidroklorid
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US20080248107A1 (en) * 2005-08-24 2008-10-09 Rubicon Research Pvt. Ltd. Controlled Release Formulation
WO2007149438A2 (en) * 2006-06-19 2007-12-27 Alpharma, Inc. Pharmaceutical compositions
US9005585B2 (en) * 2006-09-29 2015-04-14 The Procter & Gamble Company Oral compositions containing gel networks
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
WO2009088673A2 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
PE20110422A1 (es) * 2008-07-07 2011-07-01 Euro Celtique Sa Composicion farmaceutica que comprende antagonistas opioides
MY152279A (en) 2009-03-10 2014-09-15 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
UA116567C2 (uk) 2013-07-23 2018-04-10 Євро-Селтік С.А. Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації
CN114053235B (zh) * 2020-08-07 2023-07-18 广州白云山光华制药股份有限公司 茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4443428A (en) 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3750145T2 (de) * 1986-06-10 1994-11-03 Euro Celtique Sa Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids

Also Published As

Publication number Publication date
DK266889A (da) 1989-12-03
DE68904119D1 (de) 1993-02-11
IL90462A (en) 1993-01-31
JPH0225420A (ja) 1990-01-26
ES2053989T3 (es) 1994-08-01
AU610401B2 (en) 1991-05-16
DK175130B1 (da) 2004-06-14
FI892664A (fi) 1989-12-03
GR3007088T3 (no) 1993-07-30
NO176232C (no) 1995-03-01
DK266889D0 (da) 1989-06-01
IL90462A0 (en) 1990-01-18
JPH0816060B2 (ja) 1996-02-21
IE891744L (en) 1989-12-02
ZA894201B (en) 1990-03-28
GB2219207A (en) 1989-12-06
DE68904119T2 (de) 1993-06-09
IE61998B1 (en) 1994-12-14
EP0344960A2 (en) 1989-12-06
US5091189A (en) 1992-02-25
EP0344960B1 (en) 1992-12-30
GB8911629D0 (en) 1989-07-05
PT90722B (pt) 1994-11-30
EP0344960A3 (en) 1990-03-07
NO176232B (no) 1994-11-21
GB8813064D0 (en) 1988-07-06
KR0136279B1 (ko) 1998-04-25
ATE83925T1 (de) 1993-01-15
FI892664A0 (fi) 1989-06-01
NZ229372A (en) 1991-07-26
PT90722A (pt) 1989-12-29
FI93695C (fi) 1995-05-26
FI93695B (fi) 1995-02-15
KR900000077A (ko) 1990-01-30
GB2219207B (en) 1992-01-02
AU3512789A (en) 1989-12-07
CA1323834C (en) 1993-11-02
NO892229L (no) 1989-12-04

Similar Documents

Publication Publication Date Title
NO892229D0 (no) Fremgangsmaate for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament.
DK568687A (da) Hydromorphonpraeparat med reguleret afgivelse
HRP930676B1 (en) Process for the production of an active substance plaster containing estrogen
AU582920B2 (en) Continuous release pharmaceutical compositions
ATE107857T1 (de) Zusammensetzung mit kontrollierter freisetzung von dihydrocodein.
ZA881181B (en) Process for preparing a retard product containing diltiazem for a single daily administration
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
GR3007347T3 (no)
ATE5461T1 (de) Pharmazeutisches praeparat mit regulierender aktivitaet fuer den blutgefaess-tonus.
EP0269452A3 (en) Use of ketone derivatives for the manufacture of medicaments
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
JPS5626819A (en) Preventive for hypoimmunity
JPS56127307A (en) Blood-coagulation factor 8 pharmaceutical for oral administration
Ritzman Nail biting explained.
Sheehan Correct Running Pace
ATE5723T1 (de) Substituierte pyrazinyl-1,2,4-oxadiazole, verfahren zur herstellung derselben und eine dieselben enthaltende pharmazeutische zubereitung.
ATE95174T1 (de) 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und ihre verwendung.

Legal Events

Date Code Title Description
MK1K Patent expired